Related Experiment Video
Updated: Mar 19, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive
Alessandro Federico1, Silvia Zappavigna, Marcello Dallio
1Department of Clinical and Experimental Medicine, Second University of Naples, Via Pansini 5 80131 Naples, Italy. Select country.
Abstract:
Urotensin II and Urotensin-II receptors are important molecular factors that regulate vasoconstriction and all the diseases that are linked to abnormalities in blood pressure regulation (i.e.: hypertension, kidney diseases, cirrhosis etc.). Recently, Urotensin II and its receptor have also been involved in metabolic syndrome, diabetes and schizophrenia. Recent strong findings suggest that Urotensin II and its receptor are involved in the onset and development of different epithelial cancers. Indeed, it was reported that cell growth, motility and invasion in human breast, bladder, prostate, colorectal and glioblastoma cancer cells were regulated by Urotensin II and Urotensin-II receptor axis. This axis also regulated focal adhesion kinase and small Guanosine-5'-triphosphate binding proteins that likely had a role in motility and invasion mediated by Urotensin-II receptor. Additionally, its expression on tumour tissues is variably associated to the prediction of the clinical outcome of the patients and it can be considered an alternative molecular marker to be used as prognostic factor in human cancers. In conclusion, a new weapon in the treatment of human cancers is highlighting a new scenario for the future.
Insights
Urotensin II and its receptor regulate cancer cell growth and invasion. This axis shows potential as a prognostic marker and therapeutic target in various human cancers.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Urotensin II and its receptor are key regulators of vasoconstriction, impacting blood pressure-related diseases like hypertension.
- Emerging research implicates Urotensin II and its receptor in metabolic syndrome, diabetes, and schizophrenia.
- Recent evidence strongly suggests a role for Urotensin II and its receptor in the initiation and progression of epithelial cancers.
Purpose of the Study:
- To investigate the role of the Urotensin II and Urotensin-II receptor axis in the development and progression of human epithelial cancers.
- To explore the axis's influence on cancer cell behavior, including growth, motility, and invasion.
- To assess the potential of Urotensin II and its receptor as prognostic markers in cancer.
Main Methods:
- Analysis of Urotensin II and Urotensin-II receptor expression and function in various human cancer cell lines (breast, bladder, prostate, colorectal, glioblastoma).
- Investigation of the axis's regulation of key signaling molecules, including focal adhesion kinase and small Guanosine-5'-triphosphate binding proteins.
- Correlation of Urotensin II and Urotensin-II receptor expression in tumor tissues with patient clinical outcomes.
Main Results:
- The Urotensin II and Urotensin-II receptor axis was found to regulate cell growth, motility, and invasion in multiple human cancer types.
- The axis influences signaling pathways involving focal adhesion kinase and small Guanosine-5'-triphosphate binding proteins, contributing to cancer cell motility and invasion.
- Tumor expression levels of Urotensin II and its receptor are variably associated with patient prognosis, suggesting their utility as predictive markers.
Conclusions:
- The Urotensin II and Urotensin-II receptor axis plays a significant role in the pathogenesis of human epithelial cancers.
- This axis presents a promising novel therapeutic target for cancer treatment.
- Urotensin II and its receptor represent potential molecular markers for predicting cancer patient outcomes.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Regulation of Angiogenesis and Blood Supply
Hormonal Regulation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Endocrine Signaling

